Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
38,782
Views
449
CrossRef citations to date
0
Altmetric
Letter

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Juan Menga National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of China;b Shenzhen Bay Laboratory, Shenzhen, People’s Republic of ChinaView further author information
,
Guohui Xiaoa National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of China;b Shenzhen Bay Laboratory, Shenzhen, People’s Republic of ChinaView further author information
,
Juanjuan Zhanga National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Xing Hea National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Min Oua National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Jing Bia National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Rongqing Yanga National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Wencheng Dia National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Zhaoqin Wanga National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaView further author information
,
Zigang Lib Shenzhen Bay Laboratory, Shenzhen, People’s Republic of ChinaView further author information
,
Hong Gaoa National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Lei Liua National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Guoliang Zhanga National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, People’s Republic of China;b Shenzhen Bay Laboratory, Shenzhen, People’s Republic of China;c Lead ContactCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3617-5449View further author information
ORCID Icon show all
Pages 757-760 | Received 08 Mar 2020, Accepted 17 Mar 2020, Published online: 31 Mar 2020

Citations (449)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (25)

Mohamed A. Elrayess, Hadeel T. Zedan, Rand A. Alattar, Hatem Abusriwil, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, Jabeed Parengal, Bassem Alhariri, Hadi M. Yassine, Ali A. Hssain, Arun Nair, Musaed Al Samawi, Alaaeldin Abdelmajid, Jassim Al Suwaidi, Mohamed Omar Saad, Muna Al-Maslamani, Ali S. Omrani & Huseyin C. Yalcin. (2022) Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs. Blood Pressure 31:1, pages 80-90.
Read now
Yifan Que, Chao Hu, Kun Wan, Peng Hu, Runsheng Wang, Jiang Luo, Tianzhi Li, Rongyu Ping, Qinyong Hu, Yu Sun, Xudong Wu, Lei Tu, Yingzhen Du, Christopher Chang & Guogang Xu. (2022) Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. International Reviews of Immunology 41:2, pages 217-230.
Read now
Shakhi Shylesh C.M, Arya V S, Kanthlal S. K.Uma Devi P.. (2022) Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?. Clinical and Experimental Hypertension 44:1, pages 1-10.
Read now
Ryan D Castle, Michelle A Williams, William C Bushell, J Adam Rindfleisch, Christine Tara Peterson, James Marzolf, Kimberly Brouwer & Paul J Mills. (2021) Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation. Journal of Inflammation Research 14, pages 4859-4876.
Read now
Maryam Khan, Guntaj Kaur Singh, Sakina Abrar, Roshan Ganeshan, Kara Morgan & Amer Harky. (2021) Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opinion on Pharmacotherapy 22:18, pages 2455-2474.
Read now
Serap Biberoğlu, Afşin İpekci, İbrahim İkizceli, Fatih Çakmak, Yonca S Akdeniz, Altuğ Kanbakan, Dildar Konukoğlu, İbrahim M Bolayırlı, Şermin Börekçi, Seval Ürkmez & Seda Özkan. (2021) Role of Plasma Angiotensin Ii and Angiotensin-Converting Enzyme 2 Levels on Prognosis and Mortality in Hypertensive Patients with Covid-19. Biomarkers in Medicine 15:17, pages 1581-1588.
Read now
Anindita Banerjee, Upasana Ganguly, Sarama Saha, Suddhachitta Chakrabarti, Reena V Saini, Ravindra K Rawal, Luciano Saso & Sasanka Chakrabarti. (2021) Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits. Expert Review of Anti-infective Therapy 19:10, pages 1245-1258.
Read now
Abdurrahman Akyüz, Ferhat Işık, Burhan Aslan, Murat Çap, İlyas Kaya, Özgür Atlı, Ümit İnci, Ercan Taştan, Adem Aktan, Önder Bilge, Metin Okşul, Emre Aydın, Zülküf Karahan, Derya Deniz Altıntaş, Rojhat Altındağ, Mehmet Şahin Adıyaman & Bernas Altıntaş. (2021) The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients. Clinical and Experimental Hypertension 43:7, pages 587-596.
Read now
Waseem El-Huneidi, Mawieh Hamad & Jalal Taneera. (2021) Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic β cells: to be or not to be!. Islets 13:5-6, pages 106-114.
Read now
A.G.M. Sofi Uddin Mahamud, Md. Ehsanul Kabir, Abdullah Al Mamun Sohag, Chong Chen, Md. Abdul Hannan, Mahmudul Hasan Sikder, Keshab Bhattarai, Bikash Baral & Md Jamal Uddin. (2021) Food-Derived Bioactive Peptides: A Promising Substitute to Chemosynthetic Drugs Against the Dysregulated Renin-Angiotensin System in COVID-19 Patients. Journal of Biologically Active Products from Nature 11:4, pages 325-355.
Read now
Musaddique Hussain, Qaiser Jabeen, Fiaz-Ud-Din Ahmad, Kashif-Ur-Rehman, Mobeen Fatima, Saira Shaukat, Abdul Majeed, Muhammad Qasim Barkat & Ximei Wu. (2021) COVID-19 and inhibitors of the renin–angiotensin–aldosterone system. Expert Review of Anti-infective Therapy 19:7, pages 815-816.
Read now
Benedetta Bottari, Vincenzo Castellone & Erasmo Neviani. (2021) Probiotics and Covid-19. International Journal of Food Sciences and Nutrition 72:3, pages 293-299.
Read now
Serge Camelo, Mathilde Latil, Sam Agus, Waly Dioh, Stanislas Veillet, René Lafont & Pierre J. Dilda. (2021) A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality. Emerging Microbes & Infections 10:1, pages 2256-2263.
Read now
Mahtabalsadat Mirjalili, Mojtaba Shafiekhani & Afsaneh Vazin. (2020) Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Therapeutics and Clinical Risk Management 16, pages 617-629.
Read now
Solmaz Ohadian Moghadam. (2020) A Review on Currently Available Potential Therapeutic Options for COVID-19. International Journal of General Medicine 13, pages 443-467.
Read now
Kevin Bryan Lo, Ruchika Bhargav, Grace Salacup, Jerald Pelayo, Jeri Albano, Peter A. McCullough & Janani Rangaswami. (2020) Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis. Expert Review of Cardiovascular Therapy 18:12, pages 919-930.
Read now
Angel de la Cruz, Shoaib Ashraf, Timothy J. Vittorio & Jonathan N. Bella. (2020) COVID-19 and renin-angiotensin system modulators: what do we know so far?. Expert Review of Cardiovascular Therapy 18:11, pages 743-748.
Read now
Saghir Akhtar, Ibrahim F. Benter, Mohammed I. Danjuma, Suhail A. R. Doi, Syed S. Hasan & Abdella M. Habib. (2020) Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. Journal of Drug Targeting 28:7-8, pages 683-699.
Read now
Elaheh Kordzadeh-Kermani, Hossein Khalili & Iman Karimzadeh. (2020) Pathogenesis, Clinical Manifestations and Complications of COVID-19. Future Microbiology 15:13, pages 1287-1305.
Read now
Haitao Shang, Tao Bai, Yuhua Chen, Chao Huang, Shengyan Zhang, Pengcheng Yang, Lei Zhang & Xiaohua Hou. (2020) Outcomes and implications of diarrhea in patients with SARS-CoV-2 infection. Scandinavian Journal of Gastroenterology 55:9, pages 1049-1056.
Read now
Lucas A. D. Nicolau, Isabela R. S. G Nolêto & Jand V. R. Medeiros. (2020) Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight. Expert Review of Clinical Pharmacology 13:8, pages 807-811.
Read now
Sujit Kumar Debnath, Rohit Srivastava & Abdelwahab Omri. (2020) Emerging therapeutics for the management of COVID 19. Expert Opinion on Emerging Drugs 25:3, pages 337-351.
Read now
Flavia Rodrigues da Silva, Renato de Carvalho Guerreiro, Henrique de Araújo Andrade, Eduardo Stieler, Andressa Silva & Marco Túlio de Mello. (2020) Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?. Chronobiology International 37:5, pages 607-617.
Read now
Awgichew Shewasinad Yehualashet & Teshome Fentik Belachew. (2020) ACEIs and ARBs and Their Correlation with COVID-19: A Review. Infection and Drug Resistance 13, pages 3217-3224.
Read now
Ram Gelman, Areej Bayatra, Asa Kessler, Asaf Schwartz & Yaron Ilan. (2020) Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents. Emerging Microbes & Infections 9:1, pages 1397-1406.
Read now

Articles from other publishers (424)

Kaori Sakurai, Shotaro Chubachi, Takanori Asakura, Ho Namkoong, Hiromu Tanaka, Shuhei Azekawa, Takashi Shimada, Shiro Otake, Kensuke Nakagawara, Takahiro Fukushima, Ho Lee, Mayuko Watase, Tatsuya Kusumoto, Katsunori Masaki, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai & Koichi Fukunaga. (2023) Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force. Hypertension Research 47:3, pages 639-648.
Crossref
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, Marian Constantin, Georgiana Alexandra Grigore, Roxana-Elena Cristian, Grigore Mihaescu & Corneliu Ovidiu Vrancianu. (2024) Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases. Frontiers in Microbiology 14.
Crossref
M. S. Bharath, S. Ravitej, Vandana Balgi, M. C. Rakesh Raje Urs & C. S. Apoorva. (2024) A Study of Prognosis and Outcome of COVID-19-Infected Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers. APIK Journal of Internal Medicine 12:1, pages 51-54.
Crossref
Reza Mehrizi, Ali Golestani, Mohammad-Reza Malekpour, Hossein Karami, Mohammad Mahdi Nasehi, Mohammad Effatpanah, Hossein Ranjbaran, Zahra Shahali, Ali Akbari Sari & Rajabali Daroudi. (2023) Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data. Frontiers in Public Health 11.
Crossref
Zhe Zhang, Shengyong Wu, Zhiyong Wang, Yue Wang, Hui Chen, Cheng Wu & Lize Xiong. (2023) Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension. BMC Infectious Diseases 23:1.
Crossref
Laura Kate Gadanec, Jordan Swiderski, Vasso Apostolopoulos, Kostantinos Kelaidonis, Veroniki P. Vidali, Aleksander Canko, Graham J. Moore, John M. Matsoukas & Anthony Zulli. (2023) Existence of Quantum Pharmacology in Sartans: Evidence in Isolated Rabbit Iliac Arteries. International Journal of Molecular Sciences 24:24, pages 17559.
Crossref
SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, Parnian Shobeiri, Nazanin Janfaza, Farzane Behnezhad, Afsaneh Ghasemzadeh, Alireza Barzegary, Ghazal Arjmand, Alireza Noroozi, Alireza Shojaei, Ava Amiri, Farzin Vahedi, Mehrdad Mahalleh, Ahmadreza Shamsabadi, Mohsen Dashti, Amir Masoud Afsahi, Esmaeil Mehraeen & Omid Dadras. (2023) Post-Exposure Prophylaxis for COVID-19: A Systematic Review. Infectious Disorders - Drug Targets 23:5.
Crossref
Gaurav Sharma & Abhishek Sharma. (2023) Recent Insights on Drug Delivery System in Hypertension: From Bench to Market. Current Hypertension Reviews 19:2, pages 93-105.
Crossref
Amrita Chatterjee, Rajdeep Saha, Arpita Mishra, Deepak Shilkar, Venkatesan Jayaprakash, Pawan Sharma & Biswatrish Sarkar. (2023) Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19 Pandemic Era - A Review. Current Problems in Cardiology 48:8, pages 101250.
Crossref
Tarek KashourAref A. Bin AbdulhakHaytham TlayjehLeslie C. HassettAnas NomanAla MohsenMouaz H. Al-MallahImad M. Tleyjeh. (2023) Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. American Journal of Therapeutics 30:4, pages e336-e346.
Crossref
Miguel Quesada-Caballero, Ana Carmona-García, Sara Chami-Peña, Luis Albendín-García, Cristina Membrive-Jiménez, José L. Romero-Béjar & Guillermo A. Cañadas-De la Fuente. (2023) COVID-19 and the Use of Angiotensin II Receptor Blockers in Older Chronic Hypertensive Patients: Systematic Review and Meta-Analysis. Medicina 59:7, pages 1200.
Crossref
Shastri Prakash. (2023) Clinical presentation, ICU management and outcome in severe COVID-19 disease – A prospective observational study. Annals of Antivirals and Antiretrovirals 7:1, pages 010-016.
Crossref
Izabela Bolesławska, Magdalena Kowalówka, Natasza Bolesławska-Król & Juliusz Przysławski. (2023) Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence. Viruses 15:6, pages 1262.
Crossref
Konstantinos Kelaidonis, Irene Ligielli, Spiros Letsios, Veroniki P. Vidali, Thomas Mavromoustakos, Niki Vassilaki, Graham J. Moore, Weronika Hoffmann, Katarzyna Węgrzyn, Harry Ridgway, Christos T. Chasapis & John M. Matsoukas. (2023) Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics. International Journal of Molecular Sciences 24:9, pages 8454.
Crossref
Alexander Liu, Robert Hammond, Peter D. Donnelly, Juan Carlos Kaski & Anthony R. M. Coates. (2023) Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers. Journal of Internal Medicine.
Crossref
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, Graham J. Moore, Konstantinos Kelaidonis, John M. Matsoukas & Anthony Zulli. (2023) Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019. Biomolecules 13:5, pages 787.
Crossref
Jun Wang, Jierui Li, Anni Lou, Ying Lin, Qihan Xu, Wanfu Cui, Weichang Huang, Guozhen Wang, Yang Li, Jing Sun, Jiacheng Gong, Qiuping Guo, Hongshen Qiu, Ying Meng & Xu Li. (2023) Sacubitril/valsartan alleviates sepsis‐induced acute lung injury via inhibiting GSDMD ‐dependent macrophage pyroptosis in mice . The FEBS Journal 290:8, pages 2180-2198.
Crossref
Christian Albert Devaux & Jean-Christophe Lagier. (2023) Unraveling the Underlying Molecular Mechanism of ‘Silent Hypoxia’ in COVID-19 Patients Suggests a Central Role for Angiotensin II Modulation of the AT1R-Hypoxia-Inducible Factor Signaling Pathway. Journal of Clinical Medicine 12:6, pages 2445.
Crossref
Ali Nadi, Amir Abbas Shiravi, Zahra Mohammadi, Amin Aslani & Mehrdad Zeinalian. (2023) Thymus vulgaris, a natural pharmacy against COVID-19: A molecular review. Journal of Herbal Medicine 38, pages 100635.
Crossref
Yi Guo, Hao Wang, Mingzhong Xiao, Xin Guan, Yanshou Lei, Tingyue Diao, Pinpin Long, Rui Zeng, Xuefeng Lai, Hao Cai, Yutong You, Yuying Wen, Wenhui Li, Xi Wang, Yufei Wang, Qinlin Chen, Yuchan Yang, Yutong Qiu, Jishuai Chen, Huidan Zeng, Wei Ni, Youyun Zhao, Kani Ouyang, Jingzhi Wang, Qi Wang, Li Liu, Lulu Song, Youjie Wang, Huan Guo, Xiaodong Li, Tangchun Wu & Yu Yuan. (2023) Long-term outcomes of COVID-19 convalescents: An 18.5-month longitudinal study in Wuhan. International Journal of Infectious Diseases 127, pages 85-92.
Crossref
Lanfranco D'Elia, Alfonso Giaquinto, Aquilino Flavio Zarrella, Domenico Rendina, Paola Iaccarino Idelson, Pasquale Strazzullo & Ferruccio Galletti. (2023) Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic. European Journal of Internal Medicine 108, pages 28-36.
Crossref
Hongyin Chen, Jiangyun Peng, Tengyao Wang, Jielu Wen, Sifan Chen, Yu Huang & Yang Zhang. (2023) Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. Biochemical Pharmacology 208, pages 115370.
Crossref
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, Konstantinos Kelaidonis, Minos-Timotheos Matsoukas, Panagiotis Plotas, Vasso Apostolopoulos, Graham Moore, Sotirios Tsiodras, Dimitrios Paraskevis, Thomas Mavromoustakos & John M. Matsoukas. (2023) Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity. Viruses 15:2, pages 309.
Crossref
Nancy Xurui Huang, Qi Yuan, Fang Fang, Bryan P. Yan & John E. Sanderson. (2023) Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19. PLOS ONE 18:1, pages e0280280.
Crossref
E.G. Dzhusoeva & M.V. Moiseeva. (2023) COVID-19 and arterial hypertension: points of contact and outcomes of the pathological process. Scientific Bulletin of the Omsk State Medical University 3:1, pages 41-48.
Crossref
Bijan Iraj, AmirReza Moravejolahkami, Ramin Sami, Maryam Riahinezhad, Zahra Tasdighi, Arash Toghyani, NastaranSadat Hosseini, FatemehDehghan Niri & Gholamreza Askari. (2023) Association of RASis and HMG-CoA reductase inhibitors with clinical manifestations in coronavirus disease 2019 patients: Results from the Khorshid Coronavirus Disease Cohort Study. Journal of Research in Medical Sciences 28:1, pages 15.
Crossref
Paula Rodriguez-Miguelez, Allison Heefner & Salvatore Carbone. (2023) Recognizing risk factors associated with poor outcomes among patients with COVID-19. Progress in Cardiovascular Diseases 76, pages 3-11.
Crossref
Nada J. Habeichi, Ghadir Amin, Gaelle Massoud, Reine Diab, Mathias Mericskay, George W. Booz & Fouad A. Zouein. 2023. Angiotensin. Angiotensin 355 373 .
Magdi Zordok & Michael Johnstone. 2023. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease 1025 1041 .
Hanieh Maleksabet, Elham Rezaee & Sayyed Abbas Tabatabai. (2022) Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design. Current Pharmaceutical Design 28:45, pages 3583-3591.
Crossref
Mohammadreza Mirjalili, Moslem Taheri Soodejani, Mehdi Raadabadi, Ali Dehghani & Fateme Salemi. (2022) Does Losartan reduce the severity of COVID-19 in hypertensive patients?. BMC Cardiovascular Disorders 22:1.
Crossref
Sara Ahmadi Badi, Amin Malek, Alessandro Paolini, Mahya Rouhollahi Masoumi, Seyed Amirhesam Seyedi, Amir Amanzadeh, Andrea Masotti, Shohreh Khatami & Seyed Davar Siadat. (2022) Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells. Microbial Pathogenesis 173, pages 105798.
Crossref
Aysha Alkhemeiri, Shaikha Al Zaabi, Jeyaseelan Lakshmanan, Ziad El-Khatib & Niyi Awofeso. (2022) COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study. International Journal of Environmental Research and Public Health 19:23, pages 15967.
Crossref
Christian A. Devaux & Laurence Camoin-Jau. (2022) An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Frontiers in Microbiology 13.
Crossref
Holly Pavey, Spoorthy Kulkarni, Angela Wood, Yoav Ben-Shlomo, Peter Sever, Carmel McEniery & Ian Wilkinson. (2022) Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank. PLOS ONE 17:11, pages e0276781.
Crossref
Shahab Falahi, Maryam Maleki & Azra Kenarkoohi. (2022) An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction. Infectious Disorders - Drug Targets 22:7.
Crossref
Vasiliki Tsampasian, Natasha Corballis & Vassilios S. Vassiliou. (2022) Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection. Current Hypertension Reports 24:10, pages 425-433.
Crossref
Farzaneh Ketabchi & Sina Jamzad. (2022) Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System. Canadian Respiratory Journal 2022, pages 1-10.
Crossref
Dayane Caroliny Pereira Justino, David Franciole Oliveira Silva, Ketyllem Tayanne da Silva Costa, Thiffany Nayara Bento de Morais & Fábia Barbosa de Andrade. (2022) Prevalence of comorbidities in deceased patients with COVID-19: A systematic review. Medicine 101:38, pages e30246.
Crossref
Ruchika Sharma, Anoop Kumar, Jaseela Majeed, Ajit K. Thakur & Geeta Aggarwal. (2022) Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies. The Egyptian Heart Journal 74:1.
Crossref
Yujia Zhan, Honghua Yue, Weitao Liang & Zhong Wu. (2022) Effects of COVID-19 on Arrhythmia. Journal of Cardiovascular Development and Disease 9:9, pages 292.
Crossref
Sezan Vehbi, Abdullah B Yildiz & Mehmet Kanbay. (2022) Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?. Clinical Kidney Journal 15:9, pages 1639-1642.
Crossref
Gulam Navi Azad & Anoop Kumar. (2022) ACEi/ ARB and Deaths of COVID-19 Patients. Current Hypertension Reviews 18:2, pages 158-162.
Crossref
Graham J. Moore, Harry Ridgway, Konstantinos Kelaidonis, Christos T. Chasapis, Irene Ligielli, Thomas Mavromoustakos, Joanna Bojarska & John M. Matsoukas. (2022) Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System. Molecules 27:15, pages 4854.
Crossref
John M. Matsoukas, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Konstantinos Kelaidonis, Irene Ligielli, Kalliopi Moschovou, Nikitas Georgiou, Panagiotis Plotas, Christos T. Chasapis, Graham Moore, Harry Ridgway & Thomas Mavromoustakos. (2022) Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2. Biomedicines 10:7, pages 1731.
Crossref
Yasushi Matsuzawa, Kazuo Kimura, Hisao Ogawa & Kouichi Tamura. (2022) Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19. Hypertension Research 45:7, pages 1147-1153.
Crossref
Susana Cantero-Quintero, Marta Sáez-Martínez & Ana Belén Castellanos-Garrido. (2022) Evolución del paciente diagnosticado de sindrome respiratorio agudo severo por coronavirus tipo 2 en función de la comorbilidad de la población adscrita al Centro de Salud Zona VI de Albacete. Enfermería Clínica 32:4, pages 217-224.
Crossref
Susana Cantero-Quintero, Marta Sáez-Martínez & Ana Belén Castellanos-Garrido. (2022) Risk factors for severity and mortality in adults testing positive for COVID-19 in the VI Health Area of Albacete. Enfermería Clínica (English Edition) 32:4, pages 217-224.
Crossref
Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula, Renata Junqueira Moll-Bernardes, Tiago Mendonça dos Santos, Lilian Mazza, Andre Feldman, Guilherme D`Andréa Saba Arruda, Denílson Campos de Albuquerque, Andrea Silvestre de Sousa, Olga Ferreira de Souza, C. Michael Gibson, Christopher B. Granger, John H. Alexander & Renato D. Lopes. (2022) Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial. American Heart Journal 249, pages 86-97.
Crossref
Ivo Ricardo de Seabra Rodrigues Dias, Zhijian Cao & Hang Fai Kwok. (2022) Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease. Biomedicine & Pharmacotherapy 150, pages 112970.
Crossref
Harry Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis, Irene Ligielli, Graham J. Moore, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Thomas Mavromoustakos & John M. Matsoukas. (2022) Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy. Viruses 14:5, pages 1029.
Crossref
Maram Sbehat, Mohammad Altamimi, Mohammad Sabbah & Gianluigi Mauriello. (2022) Layer-by-Layer Coating of Single-Cell Lacticaseibacillus rhamnosus to Increase Viability Under Simulated Gastrointestinal Conditions and Use in Film Formation. Frontiers in Microbiology 13.
Crossref
Lisa Hasselbach, Johannes Weidner, Albrecht Elsässer & Gregor Theilmeier. (2022) Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways. Frontiers in Cardiovascular Medicine 9.
Crossref
Maria Martínez-Urbistondo, Víctor Moreno-Torres, Alberto Mora-Vargas, Esther Expósito-Palomo, Raquel Castejón-Díaz, Lidia Daimiel, Omar Ramos-Lopez, Rodrigo San-Cristóbal, Juan A. Vargas & J. Alfredo Martínez. (2022) Interaction of ACEI antihypertensive agent's administration with the inflammatory status at admission concerning COVID-19 clinical stay outcomes. Vascular Pharmacology 143, pages 106955.
Crossref
Joanna Kosacka, Claudia Berger, Uta Ceglarek, Anne Hoffmann, Matthias Blüher & Nora Klöting. (2022) Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats. Metabolites 12:4, pages 293.
Crossref
George El-Arif, Shaymaa Khazaal, Antonella Farhat, Julien Harb, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Ziad Abi Khattar, Ziad Fajloun & Jean-Marc Sabatier. (2022) Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules 27:7, pages 2048.
Crossref
T. S. Sveklina, M. S. Tyuryupov, V. A. Medvedeva, S. B. Shustov, A. N. Kuchmin & V. A. Kozlov. (2022) The effect of renin-angiotensin-aldosterone system blockers on the course of COVID-19 in patients with arterial hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 27:6, pages 653-661.
Crossref
Mousa J Alhaddad, Mohammed S Almulaify, Abdullah A Alshabib, Albatool A Alwesaibi, Mohammed A Alkhameys, Zainab K Alsenan, Hawra J Alsheef, Mohammed A Alsaghirat, Mohammed S Almomtan & Marai N Alshakhs. (2022) Relation Between Renin–Angiotensin–Aldosterone System Inhibitors and COVID-19 Severity. Cureus.
Crossref
Vitaly Ablamunits & Christopher Lepsy. (2022) Blocking TNF signaling may save lives in COVID-19 infection. Molecular Biology Reports 49:3, pages 2303-2309.
Crossref
Seyed Mohammad Seyedmehdi, Fatemeh Imanparast, Pegah Mohaghegh, Saeed Mahmoudian, Mona Karimi Dehlaqi, Fatemeh Mehvari & Mihan Pour Abdullah. (2022) Patients with severe COVID‐19 have reduced circulating levels of angiotensin‐(1–7): A cohort study. Health Science Reports 5:2.
Crossref
Kiarash Saleki, Mohammad Banazadeh, Niloufar Sadat Miri & Abbas Azadmehr. (2022) Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1. Reviews in the Neurosciences 33:2, pages 147-160.
Crossref
Matthew M Y Lee, Kieran F Docherty, Naveed Sattar, Neil Mehta, Ankur Kalra, Amy S Nowacki, Scott D Solomon, Muthiah Vaduganathan, Mark C Petrie, Pardeep S Jhund & John J V McMurray. (2022) Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy 8:2, pages 165-178.
Crossref
Berenice Martínez-Salazar, Melle Holwerda, Chiara Stüdle, Indre Piragyte, Nadia Mercader, Britta Engelhardt, Robert Rieben & Yvonne Döring. (2022) COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Frontiers in Cell and Developmental Biology 10.
Crossref
Xiaoliang Jiang, Huadong Li, Yong Liu, Linlin Bao, Lingjun Zhan, Hong Gao, Wei Deng, Jing Xue, Jiangning Liu, Xing Liu, Junli Li, Jie Wang, Shuang Wu, Mingzhe Yan, Wei Luo, Pedro A. Jose, Chuan Qin, Xiuhong Yang, Dingyu Zhang & Zhiwei Yang. (2022) The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice. Journal of Cardiovascular Translational Research 15:1, pages 38-48.
Crossref
Huai-yu Wang, Suyuan Peng, Zhanghui Ye, Pengfei Li, Qing Li, Xuanyu Shi, Rui Zeng, Ying Yao, Fan He, Junhua Li, Liu Liu, Shuwang Ge, Xianjun Ke, Zhibin Zhou, Gang Xu, Ming-hui Zhao, Haibo Wang, Luxia Zhang & Erdan Dong. (2021) Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension. Frontiers of Medicine 16:1, pages 102-110.
Crossref
Abhishek Chandra & Ashu Johri. (2022) A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 12:2, pages 190.
Crossref
Farnoosh Nozari & Nasrin Hamidizadeh. (2022) The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review. International Journal of Hypertension 2022, pages 1-8.
Crossref
Christian Zanza, Tatsiana Romenskaya, Alice Chiara Manetti, Francesco Franceschi, Raffaele La Russa, Giuseppe Bertozzi, Aniello Maiese, Gabriele Savioli, Gianpietro Volonnino & Yaroslava Longhitano. (2022) Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. Medicina 58:2, pages 144.
Crossref
Yashvardhan Batta, Cody King, John Johnson, Natasha Haddad, Myriam Boueri & Georges Haddad. (2022) Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Frontiers in Physiology 12.
Crossref
Romil Singh, Sawai Singh Rathore, Hira Khan, Abhishek Bhurwal, Mack Sheraton, Prithwish Ghosh, Sohini Anand, Janaki Makadia, Fnu Ayesha, Kiran S. Mahapure, Ishita Mehra, Aysun Tekin, Rahul Kashyap & Vikas Bansal. (2022) Mortality and Severity in COVID-19 Patients on ACEIs and ARBs—A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Frontiers in Medicine 8.
Crossref
AB Turhan, S Icten, TA Ayazoglu, Y Cag, H Ankarali & AH Turhan. (2022) ABO-Rh Blood Types and Clinical Consequences of COVID-19 Infection. Nigerian Journal of Clinical Practice 25:10, pages 1660.
Crossref
Christeena Kurian, Stephan Mayer, Gurmeen Kaur, Ramandeep Sahni, Eric Feldstein, Mena Samaan, Divya Viswanathan, Tamarah Sami, SyedFaizan Ali, Hussein Al-Shammari, Jessica Bloomfield, Michelle Bravo, Rolla Nuoman, Edwin Gulko, ChiragD Gandhi & Fawaz Al-Mufti. (2022) Bihemispheric ischemic strokes in patients with COVID-19. Brain Circulation 8:1, pages 10.
Crossref
Harry Ridgway, Graham J. Moore, Thomas Mavromoustakos, Sotirios Tsiodras, Irene Ligielli, Konstantinos Kelaidonis, Christos T. Chasapis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Russell Petty, Ioannis Karakasiliotis, Vassilis G. Gorgoulis & John M. Matsoukas. (2022) Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Computational and Structural Biotechnology Journal 20, pages 2091-2111.
Crossref
Robert C. Speth. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 528 569 .
Manoj Kumar Yadav, Indu Kumari, Bijender Singh, Krishna Kant Sharma & Santosh Kumar Tiwari. (2022) Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Applied Microbiology and Biotechnology 106:2, pages 505-521.
Crossref
Edda Russo, Lavinia Curini, Alessio Fabbrizzi & Amedeo Amedei. 2022. Microbiome in Inflammatory Lung Diseases. Microbiome in Inflammatory Lung Diseases 241 280 .
Lucia Barbieri, Daniela Trabattoni, Giulio G. Stefanini, Enrico Vizzardi, Gabriele Tumminello, Emilio Assanelli, Marianna Adamo, Carlo A. Pivato, Giovanni Provenzale, Domitilla Gentile, Marco Metra & Stefano Carugo. (2021) Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study. Frontiers in Cardiovascular Medicine 8.
Crossref
Javeria Zaheer, Hyeongi Kim & Jin Su Kim. (2021) Correlation of ACE2 with RAS components after Losartan treatment in light of COVID-19. Scientific Reports 11:1.
Crossref
Jucier Gonçalves Júnior, Estelita Lima Cândido, Gislene Farias de Oliveira & Modesto Leite Rolim Neto. 2021. Fighting the COVID-19 Pandemic. Fighting the COVID-19 Pandemic.
Amirabbas Shiravi, Aliakbar Akbari, Zahra Mohammadi, Mohammad-Sadegh Khalilian, Alireza Zeinalian & Mehrdad Zeinalian. (2021) Rosemary and its protective potencies against COVID-19 and other cytokine storm associated infections: A molecular review. Mediterranean Journal of Nutrition and Metabolism 14:4, pages 401-416.
Crossref
Chinonyerem O. Iheanacho, Valentine U. Odili & Uchenna I. H. Eze. (2021) Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic review. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Andrea Laurentius, Brian Mendel & Radityo Prakoso. (2021) Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis. The Egyptian Heart Journal 73:1.
Crossref
Hong Zhao, Chi Zhang, Xian-Xiang Chen, Qi Zhu, Wen-Xiang Huang, Yi-Lan Zeng, Ying-Xia Liu, Guo-Jun Li, Wei-Jun Du, Jing Yao, Jia-Wen Li, Peng Peng & Gui-Qiang Wang. (2021) The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive. Infectious Diseases of Poverty 10:1.
Crossref
Malindu E. Fernando, Aaron Drovandi & Jonathan Golledge. (2021) Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality. Systematic Reviews 10:1.
Crossref
Anthony Huffman, Anna Maria Masci, Jie Zheng, Nasim Sanati, Timothy Brunson, Guanming Wu & Yongqun He. (2021) CIDO ontology updates and secondary analysis of host responses to COVID-19 infection based on ImmPort reports and literature. Journal of Biomedical Semantics 12:1.
Crossref
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang & Kapaettu Satyamoorthy. (2021) Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. Journal of Ovarian Research 14:1.
Crossref
Chaoran Yu & Ernest Johann Helwig. (2021) Role of rehabilitation amidst the COVID-19 pandemic: a review. Journal of Translational Medicine 19:1.
Crossref
Michal Herman-Edelstein, Tali Guetta, Amir Barnea, Maayan Waldman, Naomi Ben-Dor, Yaron D. Barac, Ran Kornowski, Michael Arad, Edith Hochhauser & Dan Aravot. (2021) Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Cardiovascular Diabetology 20:1.
Crossref
Francisco J. de Abajo, Antonio Rodríguez-Miguel, Sara Rodríguez-Martín, Victoria Lerma, Alberto García-Lledó, F. J. de Abajo, A. Rodríguez-Miguel, S. Rodríguez-Martín, V. Lerma, A. García-Lledó, D. Barreira-Hernández, D. Rodríguez-Puyol, O. Laosa, L. Pedraza, L. Rodríguez-Mañas, M. Aguilar, I. de Pablo, M. A. Gálvez, A. García-Luque, M. Puerro, R. M. Aparicio, V. García-Rosado, C. Gutiérrez-Ortega, L. Laredo, E. González-Rojano, C. Pérez, A. Ascaso, C. Elvira, G. Mejía-Abril, P. Zubiaur, E. Santos-Molina, E. Pintos-Sánchez, M. Navares-Gómez, F. Abad-Santos, G. A. Centeno, A. Sancho-Lopez, C. Payares-Herrera & E. Diago-Sempere. (2021) Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study. BMC Medicine 19:1.
Crossref
Yihienew M. Bezabih, Alemayehu Bezabih, Endalkachew Alamneh, Gregory M. Peterson & Woldesellassie Bezabhe. (2021) Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes. BMC Infectious Diseases 21:1.
Crossref
Shamil Haroon, Anuradhaa Subramanian, Jennifer Cooper, Astha Anand, Krishna Gokhale, Nathan Byne, Samir Dhalla, Dionisio Acosta-Mena, Thomas Taverner, Kelvin Okoth, Jingya Wang, Joht Singh Chandan, Christopher Sainsbury, Dawit Tefra Zemedikun, G. Neil Thomas, Dhruv Parekh, Tom Marshall, Elizabeth Sapey, Nicola J. Adderley & Krishnarajah Nirantharakumar. (2021) Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care. BMC Infectious Diseases 21:1.
Crossref
Hee-Sung Kim, Minseok Kang & Gilwon Kang. (2021) Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective. BMC Infectious Diseases 21:1.
Crossref
Gaber El-Saber Batiha, Abdulrahim Gari, Norhan Elshony, Hazem M. Shaheen, Murtala Bello Abubakar, Sherif Babatunde Adeyemi & Hayder M. Al-kuraishy. (2021) Hypertension and its management in COVID-19 patients: The assorted view. International Journal of Cardiology Cardiovascular Risk and Prevention 11, pages 200121.
Crossref
Fatemeh Babajani, Atefeh Kakavand, Hossien Mohammadi, Armin Sharifi, Saba Zakeri, Soheila Asadi, Zeinab Mohseni Afshar, Zohreh Rahimi & Babak Sayad. (2021) COVID ‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy . Health Science Reports 4:4.
Crossref
Lingli Xie, Ziying Zhang, Qian Wang, Yangwen Chen, Dexue Lu & Weihua Wu. (2021) COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy. Frontiers in Endocrinology 12.
Crossref
O. A. Gomazkov. (2021) Damage to the Vascular Endothelium as a Leading Mechanism of COVID-19 Systemic Pathology. Biology Bulletin Reviews 11:6, pages 559-566.
Crossref
Mei PengJia HeYing XueXue YangShao LiuZhicheng Gong. (2021) Role of Hypertension on the Severity of COVID-19: A Review. Journal of Cardiovascular Pharmacology 78:5, pages e648-e655.
Crossref
Ahmed Elshafei, Emad Gamil Khidr, Ahmed A. El-Husseiny & Maher H. Gomaa. (2021) RAAS, ACE2 and COVID-19; a mechanistic review. Saudi Journal of Biological Sciences 28:11, pages 6465-6470.
Crossref
Andrea Spini, Valentina Giudice, Vincenzo Brancaleone, Maria Grazia Morgese, Silvia De Francia, Amelia Filippelli, Anna Ruggieri, Marina Ziche, Elena Ortona, Andrea Cignarella & Luigia Trabace. (2021) Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity. Pharmacological Research 173, pages 105848.
Crossref
Muhammad Manjurul Karim, Shahnaz Sultana, Rokaia Sultana & Mohammad Tariqur Rahman. (2021) Possible Benefits of Zinc supplement in CVD and COVID-19 Comorbidity. Journal of Infection and Public Health 14:11, pages 1686-1692.
Crossref
Le Huu Nhat Minh, Ali Ahmed‐Fouad Abozaid, Nam Xuan Ha, Loc Le Quang, Abdelrahman Gamil Gad, Ranjit Tiwari, Tran Nhat‐Le, Dinh Kim Quyen, Balqees AL‐Manaseer, Nguyen Dang Kien, Nguyen Lam Vuong, Ahmad Helmy Zayan, Le Huu Hanh Nhi, Kadek Agus Surya Dila, Joseph Varney & Nguyen Tien Huy. (2021) Clinical and laboratory factors associated with coronavirus disease 2019 (Covid‐19): A systematic review and meta‐analysis. Reviews in Medical Virology 31:6.
Crossref
Jesús A. Mosquera‐Sulbaran, Adriana Pedreañez, Yenddy Carrero & Diana Callejas. (2021) C‐reactive protein as an effector molecule in Covid‐19 pathogenesis. Reviews in Medical Virology 31:6.
Crossref
Yara Chamata, Kim G. Jackson, Kimberly A. Watson & Paula Jauregi. (2021) Whey-Derived Peptides at the Heart of the COVID-19 Pandemic. International Journal of Molecular Sciences 22:21, pages 11662.
Crossref
Noriaki Shimada, Hiroaki Shimada, Yoshiaki Itaya & Yasuhiko Tomino. (2020) Novel coronavirus disease in patients with end‐stage kidney disease. Therapeutic Apheresis and Dialysis 25:5, pages 544-550.
Crossref
Davide Ventura, Amy L Carr, R Duane Davis, Scott Silvestry, Linda Bogar, Nirav Raval, Cynthia Gries, Jillian E Hayes, Eduardo Oliveira, Jason Sniffen, Steven L Allison, Victor Herrera, Douglas L Jennings, Robert L PageIIII, John F McDyer & Christopher R Ensor. (2021) Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury. Open Forum Infectious Diseases 8:10.
Crossref
Jessika Iwanski, Sobhi G. Kazmouz, Shuaizhi Li, Ben Stansfield, Tori T. Salem, Samantha Perez-Miller, Toshinobu Kazui, Lipsa Jena, Jennifer L. Uhrlaub, Scott Lick, Janko Nikolich-Žugich, John P. Konhilas, Carol C. Gregorio, May Khanna, Samuel K. Campos & Jared M. Churko. (2021) Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem Cell Reports 16:10, pages 2459-2472.
Crossref
Alexis Q. Dean, William P. Bozza, Julianne D. Twomey, Shen Luo, Ancy Nalli & Baolin Zhang. (2021) The fight against COVID-19: Striking a balance in the renin–angiotensin system. Drug Discovery Today 26:10, pages 2214-2220.
Crossref
Jyoti Shekhawat, Kavya Gauba, Shruti Gupta, Purvi Purohit, Prasenjit Mitra, Mahendra Garg, Sanjeev Misra, Praveen Sharma & Mithu Banerjee. (2021) Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Indian Journal of Clinical Biochemistry 36:4, pages 440-450.
Crossref
Ying Han, Kai Yuan, Zhe Wang, Wei-Jian Liu, Zheng-An Lu, Lin Liu, Le Shi, Wei Yan, Jun-Liang Yuan, Jia-Li Li, Jie Shi, Zhong-Chun Liu, Gao-Hua Wang, Thomas Kosten, Yan-Ping Bao & Lin Lu. (2021) Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Translational Psychiatry 11:1.
Crossref
M. V. Putilina, N. V. Teplova & O. S. Gerasimova. (2021) Differentiated approach to treatment of cognitive disorders associated with SARS-CoV-2 (COVID-19), taking into account comorbidity factor. Medical alphabet:22, pages 18-24.
Crossref
Vedran Miletic, Patrik Nikolic & Dominik Kinkela. (2021) Structure-based Molecular Docking in the Identification of Novel Inhibitors Targeting SARS-CoV-2 Main Protease. Structure-based Molecular Docking in the Identification of Novel Inhibitors Targeting SARS-CoV-2 Main Protease.
Eman Sobh, Muhammad Saad Reihan, Tamer M. S. Hifnawy, Khloud Gamal Abdelsalam, Sohaila Sabry Awad, Nehal Mostafa Hamed Mahmoud, Nariman A. Sindi & Hani A. Alhadrami. (2021) Cardiovascular system and coronavirus disease-2019 (COVID-19): mutual injuries and unexpected outcomes. The Egyptian Heart Journal 73:1.
Crossref
Seyma Baslilar & Bengu Saylan. (2021) Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients. Annals of Saudi Medicine 41:5, pages 268-273.
Crossref
Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng & Deping Liu. (2021) Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis. The Journal of Clinical Hypertension 23:9, pages 1651-1663.
Crossref
Akanksha Rajput, Anamika Thakur, Amber Rastogi, Shubham Choudhury & Manoj Kumar. (2021) Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis. Computers in Biology and Medicine 136, pages 104677.
Crossref
Ganna Stepanova. (2021) Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?. Biologia Futura 72:3, pages 291-297.
Crossref
John Hanna, Padmavathi Tipparaju, Tania Mulherkar, Edward Lin, Victoria Mischley, Ratuja Kulkarni, Aliyah Bolton, Siddappa N. Byrareddy & Pooja Jain. (2021) Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges. Vaccines 9:8, pages 938.
Crossref
Adriana Fodor, Brandusa Tiperciuc, Cezar Login, Olga H. Orasan, Andrada L. Lazar, Cristina Buchman, Patricia Hanghicel, Adela Sitar-Taut, Ramona Suharoschi, Romana Vulturar & Angela Cozma. (2021) Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19—Mechanisms and Therapeutic Targets. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Xiaoping Chen, Wenjia Hu MT, Miao Yang, Jiaxin Ling, Yongxi Zhang, Liping Deng, Jinlin Li, Åke Lundkvist, Johanna F Lindahl & Yong Xiong. (2021) Risk factors for the delayed viral clearance in COVID‐19 patients. The Journal of Clinical Hypertension 23:8, pages 1483-1489.
Crossref
Tao Wang, Ruidi Tang, Honglian Ruan, Ruchong Chen, Zili Zhang, Ling Sang, Xi Su, Shuting Yi, Zhengyi Ni, Yu Hu, Lei Liu, Hong Shan, Chunliang Lei, Yixiang Peng, Chunli Liu, Jing Li, Cheng Hong, Nuofu Zhang, Nanshan Zhong & Shiyue Li. (2021) Predictors of fatal outcomes among hospitalized COVID‐19 patients with pre‐existing hypertension in China. The Clinical Respiratory Journal 15:8, pages 915-924.
Crossref
Mariele Montanari, Barbara Canonico, Evelyn Nordi, Daniela Vandini, Simone Barocci, Serena Benedetti, Eugenio Carlotti & Loris Zamai. (2021) Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?. Advances in Biological Regulation 81, pages 100820.
Crossref
Moudhi Almutlaq, Abir Abdullah Alamro, Fayhan Alroqi & Tlili Barhoumi. (2021) Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology. CJC Open 3:8, pages 1060-1074.
Crossref
Shuang Hua, Yong Yang, Danqi Zou, Jufei Li, Kaixuan Yan, Ying Xu, Xue Jiang, Xianglu Rong & Dewei Ye. (2021) COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomedicine & Pharmacotherapy 140, pages 111685.
Crossref
Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, Michael Kreuter, Jule Rüter, Srinivas Reddy Pallerla, Thirumalaisamy P. Velavan & Dennis Nurjadi. (2021) Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs. Cellular and Molecular Life Sciences 78:16, pages 5953-5976.
Crossref
Hiba Naveed, Abdallah Elshafeey, Dana Al‐Ali, Emmad Janjua, Areej Nauman, Hussam Kawas, Ridhima Kaul, Arwa Saed Aldien, Mohamed B. Elshazly & Dalia Zakaria. (2021) The Interplay Between the Immune System, the Renin‐Angiotensin‐Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID‐19: A Systematic Review. The Journal of Clinical Pharmacology 61:8, pages 987-1000.
Crossref
Sophia Newton, Benjamin Zollinger, Jincong Freeman, Seamus Moran, Alexandra Helfand, Kayla Authelet, Matthew McHarg, Nataly Montano Vargas, Robert Shesser, Joanna S. Cohen, Derek A.T. Cummings, Yan Ma & Andrew C. Meltzer. (2021) Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS‐CoV‐2 infection. Journal of the American College of Emergency Physicians Open 2:4.
Crossref
Wojciech Malchrzak, Agnieszka Mastalerz-Migas, Zbigniew Sroka & Maciej Spiegel. (2021) One Year of the COVID‐19 Pandemic. What Do We Know and What Is Yet to Come? — The Summarising Review. International Journal of Public Health 66.
Crossref
Silvia Fogacci, Federica Fogacci, Elda Favari, Peter P Toth, Claudio Borghi & Arrigo F G Cicero. (2021) Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues. European Heart Journal - Cardiovascular Pharmacotherapy 7:4, pages 346-351.
Crossref
Urja Patel, Linda Deluxe, Carlos Salama, Aaron Ross Jimenez, Adrian Whiting, Cedrick Lubin & Nancy Tarlin. (2021) Evaluation of Characteristics and Outcomes for Patients with Diabetic Ketoacidosis (DKA) With and Without COVID-19 in Elmhurst Queens During Similar Three-Month Periods in 2019 and 2020. Cureus.
Crossref
Fatih DOĞANAY & Rohat AK. (2021) Relationship between the ABO blood group and mortality among the COVID-19 patients. Journal of Health Sciences and Medicine 4:4, pages 441-444.
Crossref
Christian Zanza, Michele Fidel Tassi, Tatsiana Romenskaya, Fabio Piccolella, Ludovico Abenavoli, Francesco Franceschi, Andrea Piccioni, Veronica Ojetti, Angela Saviano, Barbara Canonico, Mariele Montanari, Loris Zamai, Marco Artico, Chiara Robba, Fabrizio Racca & Yaroslava Longhitano. (2021) Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019. Cells 10:7, pages 1752.
Crossref
Nasim Kiaie, Armita Mahdavi Gorabi, Željko Reiner, Tannaz Jamialahmadi, Massimiliano Ruscica & Amirhossein Sahebkar. (2021) Effects of Statins on Renin–Angiotensin System. Journal of Cardiovascular Development and Disease 8:7, pages 80.
Crossref
Edmond Y. Lau, Oscar A. Negrete, W. F. Drew Bennett, Brian J. Bennion, Monica Borucki, Feliza Bourguet, Aidan Epstein, Magdalena Franco, Brooke Harmon, Stewart He, Derek Jones, Hyojin Kim, Daniel Kirshner, Victoria Lao, Jacky Lo, Kevin McLoughlin, Richard Mosesso, Deepa K. Murugesh, Edwin A. Saada, Brent Segelke, Maxwell A. Stefan, Garrett A. Stevenson, Marisa W. Torres, Dina R. Weilhammer, Sergio Wong, Yue Yang, Adam Zemla, Xiaohua Zhang, Fangqiang Zhu, Jonathan E. Allen & Felice C. Lightstone. (2021) Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline. Frontiers in Molecular Biosciences 8.
Crossref
Rohan Khera, Callahan Clark, Yuan Lu, Yinglong Guo, Sheng Ren, Brandon Truax, Erica S. Spatz, Karthik Murugiah, Zhenqiu Lin, Saad B. Omer, Deneen Vojta & Harlan M. Krumholz. (2021) Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19. Journal of the American Heart Association 10:13.
Crossref
Graham J. Moore, Jose M. Pires, Konstantinos Kelaidonis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos & John M. Matsoukas. (2021) Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19. Biomolecules 11:7, pages 979.
Crossref
Keith C. Ferdinand, Tina K. Reddy & Thanh N. Vo. (2021) Global interventions in hypertension: new and emerging concepts. Current Opinion in Cardiology 36:4, pages 436-443.
Crossref
Henry Sackin. (2021) Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19. Medical Hypotheses 152, pages 110609.
Crossref
Masako Kinoshita, Kazuaki Sato, Balachandar Vellingiri, Shawn J. Green & Masami Tanaka. (2021) Inverse association between hypertension treatment and COVID-19 prevalence in Japan. International Journal of Infectious Diseases 108, pages 517-521.
Crossref
Antonia Anna Lukito, Allen Widysanto, Theo Audi Yanto Lemuel, Ignatius Bima Prasetya, Billy Massie, Mira Yuniarti, Nicolaski Lumbuun, Raymond Pranata, Cindy Meidy, Eka Julianta Wahjoepramono & Irawan Yusuf. (2021) Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study. International Journal of Infectious Diseases 108, pages 159-166.
Crossref
Terry Lee, Alessandro Cau, Matthew Pellan Cheng, Adeera Levin, Todd C. Lee, Donald C. Vinh, Francois Lamontagne, Joel Singer, Keith R. Walley, Srinivas Murthy, David Patrick, Oleksa G. Rewa, Brent W. Winston, John Marshall, John Boyd, Karen Tran, Andre C. Kalil, Russell Mcculoh, Robert Fowler, James M. Luther & James A. Russell. (2021) Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC Open 3:7, pages 965-975.
Crossref
Yasar Sattar, Pradeeksha Mukuntharaj, Mohamed Zghouzi, Abdul-Rahman M. Suleiman, Hassan Attique, Waqas Ullah, Muhammad Khawar Sana, Nathan Zaher, Maham Mehmood, Rajkumar P. Doshi, Ankur Panchal, Tanveer Mir, Muhammad Nadeem, Omar E. Ali, Mohamad Mohamed, Rodrigo Bagur, Islam Y. Elgendy, Mamas A. Mamas & M. Chadi Alraies. (2021) Safety and Efficacy of Renin–Angiotensin–Aldosterone System Inhibitors in COVID-19 Population. High Blood Pressure & Cardiovascular Prevention 28:4, pages 405-416.
Crossref
Sergej Nadalin, Hrvoje Jakovac, Vjekoslav Peitl, Dalibor Karlović & Alena Buretić‑Tomljanović. (2021) Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review). Molecular Medicine Reports 24:2.
Crossref
Yasaman Sharifi, Moloud Payab, Erfan Mohammadi-Vajari, Seyed Morsal Mosallami Aghili, Farshad Sharifi, Neda Mehrdad, Elham Kashani, Zhaleh Shadman, Bagher Larijani & Mahbube Ebrahimpur. (2021) Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review. Journal of Diabetes & Metabolic Disorders 20:2, pages 1743-1765.
Crossref
Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi & Samar Shurbaji. (2021) Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms. International Journal of Molecular Sciences 22:13, pages 6703.
Crossref
Cyril P. Landstra & Eelco J. P. de Koning. (2021) COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Frontiers in Endocrinology 12.
Crossref
Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José Torres Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María García Blanco, José López Miranda, Juan Romero-Cabrera, Carmen Herrero Gil, José Bascunana, Manuel Rubio-Rivas, Sara Pintos Otero, Verónica Martínez Sempere, Jesús Ballano Rodríguez-Solís, Ricardo Gil Sánchez, Jairo Luque del Pino, Amara González Noya, María Navas-Alcántara, Begoña Cortés Rodríguez, José Alcalá, Ana Suárez-Lombraña, Jorge Andrés Soler, Ricardo Gómez-Huelgas, José Casas-Rojo & Jesús Millán Núñez-Cortés. (2021) Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19. Journal of Clinical Medicine 10:12, pages 2642.
Crossref
Ikram Omar Osman, Cléa Melenotte, Philippe Brouqui, Matthieu Million, Jean-Christophe Lagier, Philippe Parola, Andréas Stein, Bernard La Scola, Line Meddeb, Jean-Louis Mege, Didier Raoult & Christian A. Devaux. (2021) Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Frontiers in Immunology 12.
Crossref
Elizabeth M. Sajdel-Sulkowska. (2021) A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency. Frontiers in Pharmacology 12.
Crossref
Kenichi Tamama. (2021) Potential benefits of dietary seaweeds as protection against COVID-19. Nutrition Reviews 79:7, pages 814-823.
Crossref
Livio LUZI, Loredana BUCCIARELLI, Anna FERRULLI, Ileana TERRUZZI & Stefano MASSARINI. (2021) Obesity and COVID-19: the ominous duet affecting the renin-angiotensin system. Minerva Endocrinology 46:2.
Crossref
Branka Miličić Stanić, Sydney Maddox, Aline M. A. de Souza, Xie Wu, Danial Mehranfard, Hong Ji, Robert C. Speth & Kathryn Sandberg. (2021) Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 320:6, pages R925-R937.
Crossref
Masoud Nouri‐Vaskeh, Niusha Kalami, Ramin Zand, Zahra Soroureddin, Mojtaba Varshochi, Khalil Ansarin, Haleh Rezaee, Ali Taghizadieh, Armin Sadeghi, Masoud Ahangari Maleki, Azam Esmailnajad, Parviz Saleh, Mehdi Haghdoost, Mehdi Maleki & Akbar Sharifi. (2021) Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial. International Journal of Clinical Practice 75:6.
Crossref
Chang Chu, Shufei Zeng, Ahmed A. Hasan, Carl‐Friedrich Hocher, Bernhard K. Krämer & Berthold Hocher. (2020) Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis. British Journal of Clinical Pharmacology 87:6, pages 2475-2492.
Crossref
Rahma Menshawey, Esraa Menshawey, Ayman H.K. Alserr & Antoine Fakhry Abdelmassih. (2020) JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations. Cardiovascular Endocrinology & Metabolism 10:2, pages 80-88.
Crossref
Chendi Liang, Weijun Zhang, Shuzhen Li & Gang Qin. (2021) Coronary heart disease and COVID-19: A meta-analysis. Medicina Clínica 156:11, pages 547-554.
Crossref
Chendi Liang, Weijun Zhang, Shuzhen Li & Gang Qin. (2021) Coronary heart disease and COVID-19: A meta-analysis. Medicina Clínica (English Edition) 156:11, pages 547-554.
Crossref
Ahmed A. Alrashed, Tahir M. Khan, Noara K. Alhusseini, Syed Mohammed Basheeruddin Asdaq, Mushira Enani, Bandar Alosaimi, Nada M. Alkhani, Yahya Mohzari, Maram M. Alghalbi, Wafa Alfahad, Mona A. Alanazi, Asma S. Albujaidya, Amal Ben-Akresh, Malak Almutairi, Ivo Abraham & Ahmad Alamer. (2021) Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. Journal of Infection and Public Health 14:6, pages 726-733.
Crossref
Ashkan Yahyavi, Nima Hemmati, Pegah Derakhshan, Behrooz Banivaheb, Arman Karimi Behnagh, Rozhin Tofighi, Alireza TehraniYazdi & Ali Kabir. (2020) Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study. Internal and Emergency Medicine 16:4, pages 883-893.
Crossref
Fatemeh Babaei, Mohammadreza Mirzababaei, Marjan Nassiri‐Asl & Hossein Hosseinzadeh. (2020) Review of registered clinical trials for the treatment of COVID‐19. Drug Development Research 82:4, pages 474-493.
Crossref
Jae Hyun Bae, Sun Kyu Choi, Nam Hoon Kim, Juneyoung Lee & Sin Gon Kim. (2021) Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study. Diabetes & Metabolism Journal 45:3, pages 430-438.
Crossref
Jing Ma, Xiaowei Shi, Jiong Yu, Feifei Lv, Jian Wu, Xinyu Sheng, Qiaoling Pan, Jinfeng Yang, Hongcui Cao & Lanjuan Li. (2021) Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension. Frontiers in Cardiovascular Medicine 8.
Crossref
V. B. Grinevich, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, S. P. Salikova, I. V. Gubonina, E. I. Tkachenko, S. I. Sitkin, L. B. Lazebnik, E. V. Golovanova, E. A. Belousova, P. A. Makarchuk, E. Yu. Eremina, A. S. Sarsenbaeva, D. I. Abdulganieva, L. V. Tarasova, O. A. Gromova, V. A. Ratnikov, K. V. Kozlov & A. K. Ratnikova. (2021) Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition). Experimental and Clinical Gastroenterology:3, pages 5-82.
Crossref
Hae-Young Lee, Juhee Ahn, Juhong Park, Chang Kyung Kang, Sung-Ho Won, Dong Wook Kim, Jong-Heon Park, Ki-Hyun Chung, Joon-Sung Joh, JI Hwan Bang, Cheong Hee Kang, Myoung-don Oh & Wook Bum Pyun. (2021) Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia. The Korean Journal of Internal Medicine 36:3, pages 617-628.
Crossref
Carmen Spaccarotella, Maria Mazzitelli, Serena Migliarino, Antonio Curcio, Salvatore De Rosa, Carlo Torti & Ciro Indolfi. (2021) Therapy with RAS inhibitors during the COVID-19 pandemic. Journal of Cardiovascular Medicine 22:5, pages 329-334.
Crossref
Juan M. Saavedra. (2021) Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology 36:3, pages 160-173.
Crossref
Hyun Woo Lee, Chang-Hwan Yoon, Eun Jin Jang & Chang-Hoon Lee. (2021) Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis. Thorax 76:5, pages 479-486.
Crossref
Le Ning, Jiabing Rong, Zhaocai Zhang & Yinchuan Xu. (2021) Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications. Pharmacological Research 167, pages 105409.
Crossref
Murat Oz, Dietrich Ernst Lorke & Nadine Kabbani. (2021) A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacology & Therapeutics 221, pages 107750.
Crossref
Lu Ren, Shandong Yu, Wilson Xu, James L Overton, Nipavan Chiamvimonvat & Phung N. Thai. (2021) Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. Journal of Cardiology 77:5, pages 482-491.
Crossref
Shi Jin & Weina Hu. (2021) Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Frontiers in Endocrinology 12.
Crossref
Javier Gutiérrez-Álvarez, José M. Honrubia, Raúl Fernández-Delgado, Li Wang, Carlos Castaño-Rodríguez, Sonia Zúñiga, Isabel Sola & Luis Enjuanes. (2021) Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection. mBio 12:2.
Crossref
Xiao-Ce Dai, Zhuo-Yu An, Zi-Yang Wang, Zi-Zhen Wang & Yi-Ren Wang. (2021) Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies. Frontiers in Cardiovascular Medicine 8.
Crossref
Rong Qiu, Jingwei Li, Yuxuan Xiao, Ziyi Gao, Yihang Weng, Qiran Zhang, Chengdi Wang, Hanlin GongWeimin Li. (2021) The therapeutic effect and safety of the drugs for COVID-19. Medicine 100:16, pages e25532.
Crossref
S. G. Kanorskiy. (2021) Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system. Meditsinskiy sovet = Medical Council:4, pages 59-67.
Crossref
М. V. Leonova. (2021) The effect of renin-angiotensin-aldosterone blockers on SARS-CoV-2 infection in adults: a systematic review of studies and meta-analyzes. Meditsinskiy sovet = Medical Council:4, pages 26-33.
Crossref

Displaying 200 of 449 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.